1st March 2010
Baronsmead VCT 3 plc and Baronsmead VCT 4 plc
Offer for subscription of New Ordinary Shares to raise up to approximately £
16,000,000 in aggregate ('the Joint Offer')
Baronsmead VCT 3 plc and Baronsmead VCT 4 plc ("the Companies") announce the
first allotment on 1st March 2010 of New Ordinary Shares pursuant to the Joint
Offer which has raised £11,212,000 at that date.
Based on the latest published Net Asset Values as at 19th February 2010, Offer
Prices of the New Ordinary Shares allotted on 1st March 2010 were as follows:
Baronsmead VCT 3 plc 102.5p per New Ordinary Share
Baronsmead VCT 4 plc 95.5p per New Ordinary Share
In accordance with the Prospectus dated 18th January 2010, the Offer Prices at
which the New Ordinary Shares were allotted in each Company were calculated
separately on the basis of the following formula (the "Pricing Formula"):
Latest published net asset value of an existing Ordinary Share divided by 0.945
(to allow for issue costs of 5.5 per cent.) rounded up to the nearest 0.5p per
share.
As a result, the Offer Prices have been calculated as follows:
Offer Prices of New Ordinary Shares Allotted on 1 March 2010
Baronsmead VCT 3 Baronsmead VCT 4
plc plc
(pence per New (pence per New
Ordinary Share) Ordinary Share)
Latest published NAV 96.75 90.12
Latest published NAV divided 102.38 95.37
by 0.945
Offer Price (Rounding up to 102.5 95.5
nearest 0.5p)
The was an early investment incentive whereby investors whose subscription
forms were received by 5 pm on Friday 26 February 2010 received an additional
allocation of 1 per cent of the amount of their application by way of
additional shares.
The number of shares allotted and the total number of shares in issue for each
of the Companies after the allotment are shown below:
Shares allotted (1) Shares in issue
following
allotment (2)
Baronsmead VCT 3 plc 5,601,586 65,301,139
Baronsmead VCT 4 plc 6,012,140 61,904,859
1. Includes shares allotted with respect to the early investment incentive and
any commissions waived and reinvested
2. Includes treasury shares
Dealings in the New Ordinary Shares of each Company are expected to
commence on 4 March 2010. CREST accounts are expected to be credited within
five business days of allotment and definitive documents of title are expected
to be dispatched within ten business days of allotment.
The Directors along with employees and partners of the Manager have subscribed
a total of £281,000 under the Joint Offer.
The directors of the Companies were allotted the following shares as a result
of their subscriptions to the Joint Offer:
Baronsmead VCT 3 plc Number of Number of Number of Total
Ordinary Shares Ordinary Ordinary Holding
held prior to Shares Shares held
the Joint Offer allotted after to % (1)
under the the Joint
Joint Offer Offer
Mark Cannon Brookes 180,655 5,073 185,728 0.284
Andrew Karney 82,709 - 82,709 0.127
Gillian Nott OBE 25,461 30,439 55,900 0.086
Robert Owen 10,709 - 10,709 0.016
Anthony Townsend - 7,609 7,609 0.012
1. Includes treasury shares
Baronsmead VCT 4 plc Number of Number of Number of Total
Ordinary Shares Ordinary Ordinary Holding
held prior to Shares Shares held
the Joint Offer allotted after to % (1)
under the the Joint
Joint Offer Offer
Philip Dunne 337,605 - 337,605 0.545
Ian Kirkpatrick 8,016 1,633 9,649 0.016
Robert Owen 115,703 - 115,703 0.187
Alan Pedder CBE 56,887 13,612 70,499 0.114
1. Includes treasury shares
For further information please contact:
Michael Probin VCT Investor Relations ISIS EP LLP 020 7506 5796
AI Summary Disclaimer BETA
The content you are viewing has been generated or assisted by artificial
intelligence (AI). While efforts are made to ensure accuracy and clarity, AI-generated text may
contain inaccuracies, outdated information, or subjective interpretations. This content is intended
for general informational purposes only and should not be considered professional advice or factual
confirmation.
We encourage you to independently verify any information provided,
especially if it will be relied upon for making decisions or taking action. Any reliance you place
on this material is strictly at your own risk. The AI system that produced this content cannot
assess the specifics of individual circumstances, and results may vary based on context and
individual needs.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.
Create an Account
Create your FREE account to receive personalised announcements, watchlists, market updates, investment insights and new features.
Personalise your experience
Tell us a little about yourself to receive personalised content, announcements and relevant investment opportunities.